AstraZeneca to build US.5 billion manufacturing plant in Singapore

AstraZeneca to build US$1.5 billion manufacturing plant in Singapore

May 20, 2024 / Sarkiya Ranen /



ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that enable precision therapy for cancer.



Source link

Posted in

Sarkiya Ranen

I am an editor for Ny Journals, focusing on business and entrepreneurship. I love uncovering emerging trends and crafting stories that inspire and inform readers about innovative ventures and industry insights.

Leave a Comment